Tel:+88 01313717307,+88-02-9101874
E-mail:wcrcl@wasocreditrating.com
This will close in 0 seconds
This will close in 0 seconds
Mrs. Monira Islam has been working at WCRCL as Chief Rating Officer (In-Charge) since February 2026. She has act in different positions in the rating department since joining WCRCL in 2012.
Before joining WASO, she worked with Credit Rating Information and Services Ltd. (CRISL) as a research officer since 2010.
Mrs. Monira has an MBA from Daffodil International University in Finance. In WASO and CRISL, she is a dedicated and detail-oriented financial analyst with 12 years of experience. In this time, she completed many rating assignments, including ratings of general insurance, MFIs, power plants, large corporations, projects of various industries, and SME clients. As a senior financial analyst, she performs quantitative and statistical analysis, accounting, and decision-making with strong analytical skills. She also assists in training and, as needed, supervises her team members. Experienced in client relations, effective communication, report generation, process development, and documentation.
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
where to buy priligy usa Patients who withdrew from the study were censored at the time of withdrawal; any data collected prior to withdrawal were included in the analysis
Products are prioritized within their grouping cheap cytotec without dr prescription Some types of chemotherapy, such as bleomycin available as a generic drug, cladribine available as a generic drug, L asparaginase Elspar, and paclitaxel Taxol and other taxane based chemotherapies
cytotec prices The search strategy for this literature review was conducted by using the key words aromatase inhibitor and bone loss OR aromatase inhibitor and osteoporosis in the MEDLINE PubMed database
finasteride coupon 90-day supply It is important to identify the biomarkers predicting response to TAM so that an alternative therapeutic regimen can be used